Cafepharma Today

January 30 2025 - Novo Nordisk commences fresh trials for CagriSema
Novo Nordisk commences fresh trials for CagriSema
Express Scripts becomes latest PBM to follow in Mark Cuban's footsteps
With efficacy assured, Merck halts another trial of blockbuster-to-be Winrevair
Sanofi plans €5 billion buyback, sees higher profit growth
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Indevus, Tiva ink development deal
Bizjournals.com
Friday, September 26, 2008 - 3:55pm
tags:
FDA reviews experimental use of anemia drugs in stroke patients after report on death rates
Yahoo/AP
Friday, September 26, 2008 - 3:46pm
tags:
NPS Pharmaceuticals shares fall as partner GlaxoSmithKline ends midstage drug study
Yahoo/AP
Friday, September 26, 2008 - 3:45pm
tags:
ImClone Systems in payment dispute over Erbitux
Yahoo/AP
Friday, September 26, 2008 - 3:45pm
tags:
Will Lilly Pull An Upset (Like Oregon State Over USC) With Effient?
CNBC
Friday, September 26, 2008 - 3:44pm
tags:
Snap Up This Snapback Biotech Play
The Street.com
Friday, September 26, 2008 - 3:43pm
tags:
Indevus and FDA Agree on Path Forward for NEBIDO(R)
Yahoo
Friday, September 26, 2008 - 9:42am
tags:
Savient Pharmaceuticals still reviewing options for lead drug candidate, expects FDA filing
Yahoo/AP
Friday, September 26, 2008 - 9:41am
tags:
Novo Nordisk: confident in franchise sustainability
Marketwatch
Friday, September 26, 2008 - 9:35am
tags:
Cypress Bioscience rises as analysts say potential fibromyalgia drug likely to be approved
Yahoo/AP
Friday, September 26, 2008 - 9:32am
tags:
Glaxo ends study on NPS osteoporosis drug
Yahoo/AP
Friday, September 26, 2008 - 9:30am
tags:
Icahn Biotech Stakes Rise on Drugmaker Demand as Markets Gyrate
Bloomberg
Friday, September 26, 2008 - 8:49am
tags:
Alpharma Rejects King Takeover, Cites More Bidders
Bloomberg
Friday, September 26, 2008 - 8:48am
tags:
FDA decision on Eli Lilly's blood thinner critical to company outlook
Yahoo/AP
Friday, September 26, 2008 - 8:42am
tags:
What's Happening at Pfizer Right Now?
Seeking Alpha
Friday, September 26, 2008 - 8:14am
tags:
Merck to Report (Some) Payments to Doctors, Medical Education Groups
WSJ Online
Friday, September 26, 2008 - 8:13am
tags:
Eli Lilly's Dose of Disclosure
Motley Fool
Friday, September 26, 2008 - 8:11am
tags:
Wyeth Working Thru Setbacks
Yahoo/Zacks.com
Friday, September 26, 2008 - 8:10am
tags:
Wyeth: Menopause drug reduces multiple symptoms
Yahoo/AP
Friday, September 26, 2008 - 8:09am
tags:
Pfizer shares rise amid layoff rumors
Marketwatch
Friday, September 26, 2008 - 8:08am
tags:

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Annoying Enzyme Activity
In the Pipeline
Drug Channels News Roundup, January 2025: Mark Cuban Fixes Healthcare, Payers’ G2N Bubble, Pharmacists Rejoice, 340B Shenanigans, and 46Brooklyn vs. Mushrooms
Drug Channels
Bacteria (and Their Metabolites) and Depression
In the Pipeline
Some Good MASH/NASH News For Once
In the Pipeline
Attacking Estrogen-Receptor-Positive Breast Cancer
In the Pipeline
New Study Reveals Five Crucial Priorities Shaping The Future of Patient Services
Drug Channels
Killing Cancer Patients (Once the Payments Clear)
In the Pipeline
The Big Three PBMs’ 2025 Formulary Exclusions: Humira, Stelara, Private Labels, and the Shaky Future for Pharmacy Biosimilars
Drug Channels
Clinical Trial Readouts Are A-Comin'
In the Pipeline

Latest Jobs

Sr. Training Manager Learning & Performance- Commercial Sales
Yardley, Pennsylvania, United States
EVERSANA
Psychiatry Account Manager - Midland, TX
Midland, Texas, US
Lundbeck
Psychiatry Account Manager - Newport News, VA
Newport News, Virginia, US
Lundbeck
Psychiatry Account Manager - Saint Louis South, MO
Saint Louis, Missouri, US
Lundbeck
Psychiatry Account Manager - Macon, GA
Macon, Georgia, US
Lundbeck
Psychiatry Account Manager - Plano, TX
Plano, Texas, US
Lundbeck
Psychiatry Account Manager - College Station, TX
College Station, Texas, US
Lundbeck
Pharmaceutical Sales Representative- Associate Territory Manager- Cardiometabolic Health
Tallahassee, Florida
Eli Lilly and Company
Manager, Associates Membership Sales
Alexandria, Virginia, United States
Health Industry Distributors Association
Pharmaceutical Sales Representative - Associate Territory Manager, Cardiometabolic Health
Jacksonville, Florida
Eli Lilly and Company
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information